Nathan Richoz

9.4k citations
32 papers · 6.8k · 8 hit papers · h-index 23

Impact in

    • SARS-CoV-2 and COVID-19 Research
    • COVID-19 Clinical Research Studies
    • SARS-CoV-2 detection and testing
  • Immunology top 5%
    • T-cell and B-cell Immunology

Papers in

Nathan Richoz

32 papers receiving 6.7k citations

Nathan Richoz's Hit Papers

Spatially resolved multiomics of human cardiac niches 2023 · 244 citations
2440+2+5Years since publication2505007501k

Peers

Nathan Richoz
Comparison fields: 5 of 128
  • Infectious Diseases 3.7k
  • Immunology 541
  • Modeling and Simulation 133
  • Molecular Biology 1.3k
  • Nephrology 180
Replace Daniel J. Kim with:
Daniel J. Kim United States
James E. D. Thaventhiran United Kingdom
Giuseppe DeIuliis United States
Rachel Linger United Kingdom
Jessica Nouws United States
Eleanor F. Dewhurst United Kingdom
Hans‐Martin Jäck Germany
Kadi-Ann Rose United States
Esther Bulle Netherlands
Hannah Stark United Kingdom
Nathan Richoz relative to Daniel J. Kim United States Daniel J. Kim's profile →
Citations per field
00.5×2×4×6×7.2×
Daniel J. Kim · 1×
Citations per year

Countries citing papers authored by Nathan Richoz

Since Specialization
Citations

This map shows the geographic impact of Nathan Richoz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Richoz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Richoz more than expected).

Fields of papers citing papers by Nathan Richoz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan Richoz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Richoz. The network helps show where Nathan Richoz may publish in the future.

Co-authors

The 25 scholars most cited alongside Nathan Richoz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nathan Richoz Line = papers co-authored together Nathan Richoz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#Work
1
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
Hit paper breakdown →
20211003
2
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
Hit paper breakdown →
2022873
3
SARS-CoV-2 evolution during treatment of chronic infection
Hit paper breakdown →
2021814
4
Cross-tissue immune cell analysis reveals tissue-specific features in humans
Hit paper breakdown →
2022670
5
Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors
Hit paper breakdown →
2018566
6
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2
Hit paper breakdown →
2021564
7
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Hit paper breakdown →
2021530
8 2019328
9
Spatially resolved multiomics of human cardiac niches
Hit paper breakdown →
2023244
10 2020229
11 2020178
12 2022152
13 202195
14 202268
15 201966
16 201653
17 202052
18 202452
19 202250
20 202238

About Nathan Richoz

Nathan Richoz is a scholar working on Infectious Diseases, Immunology, Rheumatology, Neurology and Molecular Biology, having authored 32 papers that have together received 6.8k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (10 papers), Single-cell and spatial transcriptomics (6 papers), T-cell and B-cell Immunology (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Systemic Lupus Erythematosus Research (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Circadian rhythm and melatonin (1 paper) and Rheumatoid Arthritis Research and Therapies (1 paper). The work is most often cited by research in Infectious Diseases (3.7k citations), Immunology (541 citations), Modeling and Simulation (133 citations), Molecular Biology (1.3k citations) and Nephrology (180 citations). Nathan Richoz has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Menna Ruth Clatworthy, Zewen Kelvin Tuong, Richard M. Siegel, Kevin W. Loudon, John R. Ferdinand, Kathleen R Bashant, Mariana J. Kaplan, Gemma D. Banham, Laurence S. C. Lok and Randall S. Johnson. Their work appears in journals such as Nature, Nature Communications, Science, Cell Reports and Nature Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact